Oral Cancer Screening in Dental Set Up

Saini, Rajiv

doi:10.7439/ijbar.v6i3.1829

Cited by 5 publications

(9 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…OralID uses "fluorescence technology." OralID's fluorescence technology uses a blue light (435-460 nm) that allows a clinician to identify oral cancer, pre-cancer and other abnormal lesions at an earlier stage [7] .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Role of OralID Guided Biopsy in Diagnosis of Oral Epithelial Dysplastic Lesions

Sadakah

Saad

Megahed

et al. 2021

OMX

View full text Add to dashboard Cite

Recent advancements in oral cancer research have led to the development of potentially useful diagnostic tools at the clinical level like OralID device which help in early detection of oral mucosal lesions especially the dysplastic ones which could be of value in screening of suspected oral mucosal lesions and for the early detection of oral cancer [2] .So, in this study we will evaluate the diagnostic accuracy of OralID device in early diagnosis and guiding the margins of biopsy in management of oral mucosal lesions.

show abstract

Section: Introductionmentioning

confidence: 99%

“…When the blue light from OralID shines on healthy oral tissue, it fluoresces green. However, when it shines on abnormal tissue, it appears dark due to a lack of fluorescence [7] (Figure 1).…”

Section: Introductionmentioning

confidence: 99%

The Role of OralID Guided Biopsy in Diagnosis of Oral Epithelial Dysplastic Lesions

Sadakah

Saad

Megahed

et al. 2021

OMX

View full text Add to dashboard Cite

show abstract

“…Of all oral neoplasms squamous cell carcinoma is one of the most frequent tumors affecting the oral cavity. Recent studies have shown that more than 90% of malignant neoplasms affecting the oral cavity are of squamous cell carcinoma type [1,2]. In addition to the high prevalence of the disease; reports from local centers and worldwide indicate an ongoing increase in the incidence of the disease.…”

Section: Introductionmentioning

confidence: 99%

“…Poh et al [13] in Canada has used a similar device to detect field change around squamous cell carcinoma and found a positive correlation between loss of heterozygosity and fluorescence visualization loss. In this study we intended to investigate the ability of this method to delineate surgical margins at real time using a new auto-fluorescence device named Oral ID, a relatively cost effective device that detects cancerous and precancerous lesions by the principle of fluorescence [2,13]. Oral ID cancer screening device has gained the US food and drug administration clearance yet no studies on the general population have been carried out to assess the validity of this device.…”

Section: Introductionmentioning

confidence: 99%

Oral ID® as an adjunctive tool for surgical margin assessment in patients with oral squamous cell carcinoma: a comparative study

MOHAMED¹,

MOHAMMED²,

SULAIMAN³

2021

Braz. Dent. Sci.

View full text Add to dashboard Cite

Objective: The condition of the resected margin in oral squamous cell carcinoma continues to be an important prognostic factor; the use of optic technology could help surgeons in determining the margin status at real time. This study aims to evaluate Oral ID, a hand held device that uses the principal of auto-fluorescence to determine surgical safe margins in patients with oral squamous cell carcinoma, and to compare the results with those of the conventional 1 cm margin method. Material and Methods: This study was a descriptive, comparative analytical study carried out at

show abstract

“…Additionally, the marked cost savings of the OralID in the developing world, where the comparative high cost of equipment is the primary hindrance to the latest technologies, will allow dramatic increase in the number of people that can be screened. 11 The widespread use of this cost effective and results-oriented device will open new dimensions in the screening and treatment for oral cancer patients. This innovative device works on the fundamental principle that 'Initial diagnosis influences final prognosis'.…”

mentioning

confidence: 99%

Oral Cancer Screenings: Have We turned the Corner?

Pikkula¹

2015

International Journal of Experimental Dental Science

View full text Add to dashboard Cite

Cancer is the second most cause of morbidity and mortality in the world today after cardiovascular diseases. Six million people die due to cancer each year. Detecting cancer in its early stages dramatically increases the survival rates as compared to its detection in later stages. 1 Most major cancers are tracked by their 5-year survival rate-the percentage of patients that are diagnosed with cancer and are still alive after 5 years. With advancements of technologies and screenings, most cancers have a survival rate greater than 50%, a number that is steadily increasing. On the contrary, there are some cancers that have a survival rate that is surprisingly low.When looking at the 5-year survival rates of the worst cancers (pancreas 7%, liver 17%, lung 17%, esophagus 18% and stomach 28%), there is a common trend: these are all internal organs with no accepted screening protocol, and symptoms only occurring until late stages and metastasis. Not that this is acceptable, but it is understandable given the complexities of regular screenings for these organs. What is not understandable is that the 5-year survival rate of oral cancer has not improved in decades. With easy to access tissue of the oral cavity, along with advancements in technology and protocols, there are no excuses for oral cancer to be discovered in late stages, regardless of what country it may be.Oral cancer, also called 'head and neck cancer', has a low 5-year survival rate of 63%, even in developed parts of the world. 2 The reason for the low survival rate is that the majority of oral cancers are discovered in the latter stages of the disease, often after it has metastasized. 3 In settings with low resources, a similar low survival rate exists. However, this author believes that the similarity in the mortality rates are due to different reasons depending on the resource setting.In the United States, e.g. the de facto medical professional to identify oral cancer is the dentist. For almost a decade, the advanced technology of fluorescence has been on the market as a general screening tool, but this technology occupies less than 10% of the American dental offices. At American dental schools there may be a few of instruction hours covering pathology and cancer, while the vast majority of time is dealing with teeth. As a general rule, American dentists are uncomfortable talking with their patients about the dreaded 'C' word; life and death discussions are outside their comfort zone. It is a difficult task introducing them to technology and protocols outside of their training and expertise. Lastly, the lack of insurance reimbursement is an impediment to implementing this technology. Dental insurance is an unpredictable creature which may not compensate the dental office for their time. This is why many offices have moved to a strict fee-for-service model. This also is problematic in that trying to amortize a multithousand dollar piece of equipment from a cash pay patient is difficult. Furthermore, an additional cost of $2.50 USD per patient in disposable ...

show abstract

Oral Cancer Screening in Dental Set Up

Cited by 5 publications

References 20 publications

The Role of OralID Guided Biopsy in Diagnosis of Oral Epithelial Dysplastic Lesions

The Role of OralID Guided Biopsy in Diagnosis of Oral Epithelial Dysplastic Lesions

Oral ID® as an adjunctive tool for surgical margin assessment in patients with oral squamous cell carcinoma: a comparative study

Oral Cancer Screenings: Have We turned the Corner?

Contact Info

Product

Resources

About